TL;DR
Researchers have sequenced and analyzed the genome of a novel Streptococcus oralis strain, CRC211, isolated from colorectal tumor tissue. This strain possesses unique genomic features, including prophage regions and numerous virulence and antibiotic resistance genes, suggesting its potential role in promoting colorectal cancer progression and offering avenues for novel diagnostic and therapeutic strategies.
What Problem Does This Paper Address?
The human gut microbiome, and specifically the intratumoral microbiota, is increasingly recognized as a critical player in cancer development and progression. While many studies have identified associations between specific bacteria and colorectal cancer (CRC), understanding the precise mechanisms by which these microbes contribute to tumorigenesis, immune evasion, and therapeutic resistance remains a significant challenge. Distinguishing causative agents from mere passengers, and elucidating their functional roles within the complex tumor microenvironment, is crucial for developing targeted interventions. This paper addresses this gap by providing a deep genomic characterization of a novel Streptococcus oralis strain (CRC211) isolated directly from CRC tumor tissue, aiming to uncover its potential oncogenic mechanisms and clinical relevance.
Methods
The study employed a multi-faceted approach combining advanced sequencing and bioinformatics techniques:
- Whole-Genome Sequencing: High-quality sequencing was performed using both Illumina NovaSeq 6000 (for short reads) and PacBio Sequel II (for long reads) platforms. This hybrid approach allows for accurate assembly and resolution of complex genomic regions.
- Genome Assembly and Polishing: Long-read data from PacBio was used for initial assembly, followed by short-read data from Illumina to close gaps and correct errors, resulting in a high-quality, contiguous genome.
- Gene Prediction and Functional Annotation: Standard bioinformatics tools like Prokka were used for gene prediction. Functional annotation involved aligning predicted protein sequences against multiple comprehensive databases, including NR, COG, GO, KEGG, VFDB (Virulence Factors Database), and CARD (Comprehensive Antibiotic Resistance Database), to identify genes involved in various biological processes, metabolic pathways, and virulence mechanisms.
- Comparative Genomics: This involved aligning the CRC211 genome against a curated set of S. oralis reference strains from diverse geographical locations and clinical sources. Techniques like Average Nucleotide Identity (ANI) and pan-genome analysis were used to assess genomic similarity, identify core and accessory genes, and understand the strain's evolutionary relationship and genomic plasticity.
- Phylogenetic Analysis: 16S rRNA gene sequencing and whole-genome-based phylogenetic trees were constructed to confirm the taxonomic placement of CRC211 and its relationship to other S. oralis strains.
- Taxonomic Validation: Digital DNA-DNA hybridization (dDDH) and the Genome Taxonomy Database Toolkit (GTDB-Tk) were employed for robust taxonomic assignment.
Datasets
The study utilized publicly available whole-genome sequences of 29 Streptococcus oralis strains from the NCBI RefSeq database for comparative genomic analysis. The raw sequencing data for the novel strain Streptococcus oralis CRC211 has been uploaded to the National Center for Biotechnology Information (NCBI) under accession GEO number: GSE294724.
Key Insights and Ideas
- CRC211 as a CRC-Associated Strain: The isolation of CRC211 directly from tumor tissue, coupled with its genomic profile, strongly suggests its association with colorectal cancer.
- Genomic Plasticity and Adaptation: The "open pan-genome" of S. oralis, as demonstrated by this study, indicates a high degree of genomic flexibility. This allows strains like CRC211 to adapt to specific niches, such as the tumor microenvironment, by acquiring or losing genes.
- Prophages as Potential Virulence Enhancers: The presence of two intact prophage regions in CRC211 is significant. Prophages are known to carry genes that can enhance bacterial pathogenicity, including toxins and immune evasion factors, and can facilitate horizontal gene transfer of virulence and antibiotic resistance genes.
- Multifaceted Virulence Arsenal: CRC211 possesses a rich set of genes related to adhesion (e.g., pili), biofilm formation, and oxidative stress response. These mechanisms are crucial for colonizing the host, evading immune clearance, and establishing a persistent presence within the tumor.
- Antimicrobial Resistance as a Survival Mechanism: The significant number of antibiotic resistance genes (75 in total) found in CRC211 suggests its ability to survive in the presence of antibiotics, potentially contributing to therapy failure and the development of a dysbiotic niche that favors tumor progression.
- Metabolic Adaptability: The enrichment of genes involved in amino acid and carbohydrate metabolism highlights CRC211's capacity to utilize nutrients available in the tumor microenvironment, such as those derived from necrotic tumor cells, further supporting its survival and growth.
Key Results
- The assembled genome of S. oralis CRC211 is 15.03 Mb with a GC content of 40.94%.
- The genome contains 2 prophage regions totaling 160.5 kb.
- Functional annotation identified 3,674 genes, with significant enrichment in amino acid and carbohydrate metabolism pathways.
- 116 virulence factors were identified, including adhesins and biofilm-associated genes.
- 75 antimicrobial resistance genes were annotated, including those conferring resistance to tetracyclines and macrolides.
- Comparative genomic analysis showed CRC211 shares 92.29% average nucleotide identity with reference S. oralis strains, placing it within the species but indicating notable divergence.
- Pan-genome analysis revealed an open genome structure with 1,222 conserved core genes.
Limitations and Future Work
- Mechanistic and In Vivo Validation: The study acknowledges that while genomic features suggest mechanisms for CRC211's role in tumorigenesis, experimental validation is essential. Future work should involve in vivo studies using gnotobiotic or conventional mouse models of CRC to establish causality.
- Host-Microbe Interactions: The precise localization of CRC211 within tumors and its detailed impact on immune cells and the tumor microenvironment require further investigation, potentially using single-cell spatial transcriptomics.
- Therapeutic Targeting: While prophage-encoded virulence factors are identified as potential targets, their specific roles and therapeutic potential need to be explored.
- Clinical Translation: The study suggests several clinical applications, including diagnostic biomarkers for non-invasive CRC detection, phage-mediated therapies, and microbiota modulation strategies. These avenues require further research and development to be translated into clinical practice.
- Strain-Specific Evolution: The genomic divergence of CRC211 from other S. oralis strains warrants further investigation into the specific evolutionary pressures that have shaped its adaptation to the tumor environment.
Summary updated